This inventor holds 1 USPTO granted patent. Top assignee: Knoll Aktiengesellachaft. Active years: 1998.
Company Filing History:
Years Active: 1998
Title: Michael Henry Hockley: Innovator in Immunomodulatory Compounds
Introduction
Michael Henry Hockley is a notable inventor based in Nottingham, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds with immunomodulatory activity. His work has implications for various therapeutic applications.
Latest Patents
Hockley holds a patent for "Azolyl-cyclic amine derivatives with immunomodulatory activity." This patent describes a compound of the formula (I), which possesses immunomodulatory activity or a pharmaceutically acceptable salt thereof. The patent also details pharmaceutical compositions comprising the compound and processes for making and using it. He has 1 patent to his name.
Career Highlights
Hockley is associated with Knoll Aktiengesellschaft, where he has been involved in innovative research and development. His work has contributed to advancements in pharmaceutical sciences, particularly in the area of immunology.
Collaborations
Throughout his career, Hockley has collaborated with esteemed colleagues, including David George Webber and Gerald Bernard Tometzki. These collaborations have fostered a productive environment for innovation and research.
Conclusion
Michael Henry Hockley is a distinguished inventor whose work in immunomodulatory compounds has the potential to impact the pharmaceutical industry significantly. His contributions and collaborations highlight the importance of innovation in addressing health challenges.